- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
Azasetron is a 5-HT3 receptor antagonist used to treat nausea and vomiting caused by chemotherapy and radiotherapy. It is also used to treat irritable bowel syndrome with diarrhea. Azasetron is a member of the class of drugs known as serotonin receptor antagonists, which work by blocking the action of serotonin, a neurotransmitter that can cause nausea and vomiting. Azasetron is available in both oral and intravenous formulations.
Azasetron is a widely used drug in the gastrointestinal drugs market. It is used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy and radiotherapy, as well as irritable bowel syndrome with diarrhea. It is also used to treat postoperative nausea and vomiting.
The companies in the Azasetron market include Merck & Co., Inc., GlaxoSmithKline plc, Sanofi-Aventis, Pfizer Inc., and Novartis AG. Show Less Read more